Mirae Asset Global Etfs Holdings Ltd. Revolution Medicines, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 7,472 shares of RVMD stock, worth $349,017. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,472
Previous 109,004
93.15%
Holding current value
$349,017
Previous $3.85 Million
92.89%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding RVMD
# of Institutions
333Shares Held
195MCall Options Held
908KPut Options Held
723K-
Vanguard Group Inc Valley Forge, PA15.8MShares$736 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.3MShares$669 Million2.37% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$626 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$495 Million0.2% of portfolio
-
Wellington Management Group LLP Boston, MA10.3MShares$479 Million0.07% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $4.1B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...